Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |